118 results
Page 4 of 6
8-K
yu548jg jsa
26 Jan 09
Departure of Directors or Principal Officers
12:00am
425
EX-99.1
7oeh qecs1
26 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.1
ntv5tuz
25 Sep 08
Ligand to Acquire Pharmacopeia Webcast
12:00am
425
33a7lax
25 Sep 08
Business combination disclosure
12:00am
425
EX-99.1
d4pioc
25 Sep 08
Business combination disclosure
12:00am
425
EX-99.2
7k303hi3bqa2pzm6
24 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.2
9jj445bgumncjmq45w2
24 Sep 08
1 Joseph A. Mollica, Ph.D., Chairman of the Board, Interim President & CEO, Pharmacopeia John L. Higgins, President & CEO
12:00am
8-K
EX-10
6668f33smrbr5foixd
4 May 07
Termination of a Material Definitive Agreement
12:00am
424B3
tqt8w5
4 May 07
Prospectus supplement
12:00am
424B3
iak1pv1n
6 Feb 07
Prospectus supplement
12:00am
8-K
EX-99.1
a5rzgb
6 Feb 07
Ligand Announces Corporate Restructuring
12:00am
DEFM14A
l5wt3j
24 Jan 07
Proxy related to merger
12:00am
424B3
a6wy7tun8z7kg264e
16 Jan 07
Prospectus supplement
12:00am
CORRESP
2g0j9je6ledtrmmw1oy
14 Dec 06
Correspondence with SEC
12:00am
PRER14A
z84wfebl
14 Dec 06
Preliminary revised proxy
12:00am
PREM14A
y86hmhd
6 Nov 06
Preliminary proxy related to merger
12:00am
8-K
EX-99
qid93mo2 umtuay
11 Sep 06
Regulation FD Disclosure
12:00am